Skip to main content

Bladder Cancer Clinical Trials

Review the bladder cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 151-174 of 174

Optimal Screening Strategy for Bladder Cancer in at Risk Patients
Status: Active
Location: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
Status: Active
Location: 2 locations
Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE Trial)
Status: Active
Location: 2 locations
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
Status: Active
Location: 3 locations
Mood Alterations in the Patients with Non-Muscle Invasive Bladder Cancer Treated with Bacillus Calmete-Guerin
Status: Active
Location: 2 locations
Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Blue Light Cystoscopy With Cysview® Registry
Status: Active
Location: 12 locations
ADSTILADRIN Early Utilization and Outcomes in the Real World Setting
Status: Active
Location: 8 locations
Patient-Derived Xenografts to Reduce Cancer Health Disparities
Status: Active
Location: 7 locations
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Status: Active
Location: 7 locations
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
Status: Active
Location: 4 locations
Collecting and Studying Blood and Tissue Samples from Patients with Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
Status: Active
Location: 2 locations
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
Status: Active
Location: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
Measuring Surgical Recovery in Participants Undergoing Radical Cystectomy
Status: Active
Location: 15 locations
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Longitudinal Bladder Cancer Study for Tumour Recurrence
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Evaluation for NCI Surgery Branch Clinical Research Protocols
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
The Comparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) for Bladder Cancer Study 2
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Rapid Autopsy and Procurement of Cancer Tissue
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer
Status: Active
Location: See ClinicalTrials.gov
Circulating Tumor DNA Exposure in Peripheral Blood
Status: Active
Location: See ClinicalTrials.gov